Sumitomo Pharma Co., Ltd. (SMDPY) Financials

SMDPY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 5.1 billion 3.2 billion
Dec. 31, 2025 5.2 billion 3.4 billion
Sept. 30, 2025 5.3 billion 3.5 billion
June 30, 2025 5.1 billion 3.9 billion

SMDPY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 183.3 million ?
Dec. 31, 2025 153.8 million ?
Sept. 30, 2025 120.0 million ?
June 30, 2025 -11.6 million ?

SMDPY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -5.2 million
Dec. 31, 2025 57.3 million
Sept. 30, 2025 602.6 million
June 30, 2025 77.9 million

SMDPY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 278.6 million 1.1 billion -
Dec. 31, 2025 366.2 million 1.7 billion -
Sept. 30, 2025 264.2 million 1.8 billion -
June 30, 2025 142.2 million 1.8 billion -

SMDPY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 2.5 million
Sept. 30, 2025 2.7 million
June 30, 2025 2.8 million

SMDPY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.7 million 102.8 million 274.5 million -
Dec. 31, 2025 8.4 million 67.3 million 279.0 million -
Sept. 30, 2025 7.3 million 64.3 million 281.2 million -
June 30, 2025 10.2 million 56.8 million 247.9 million -

SMDPY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 672.9 million 326.8 million
Dec. 31, 2025 783.9 million 360.3 million
Sept. 30, 2025 818.9 million 313.4 million
June 30, 2025 751.0 million 306.7 million

SMDPY

Price: $9.78

52 week price:
4.78
24.48

Earnings Per Share: 1.70 USD

P/E Ratio: 6.43

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 4.4 billion

Links: